|
|
|
|
|
26.
12226 Accesses
|
Postprandial hyperglycemia as an etiological factor in vascular failure
Koichi Node, Teruo Inoue Cardiovascular Diabetology 2009, 8:23 (29 April 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central |
|
|
|
27.
11826 Accesses
|
Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes
Maria Kompoti, Anargiros Mariolis, Alevizos Alevizos, Ioannis Kyriazis, Ioannis Protopsaltis, Eleni Dimou, Ioannis Lentzas, Dimitrios Levisianou, Afroditi Gova, Andreas Melidonis Cardiovascular Diabetology 2006, 5:21 (4 October 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
28.
11609 Accesses
|
Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review
Peter Bramlage, Joerg Hasford Cardiovascular Diabetology 2009, 8:18 (27 March 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
29.
11098 Accesses
|
Cardiovascular adaptations to exercise training in postmenopausal women with type 2 diabetes mellitus
Jonathan McGavock, Sandra Mandic, Richard Lewanczuk, Matthew Koller, Isabelle Muhll, Arthur Quinney, Dylan Taylor, Robert Welsh, Mark Haykowsky Cardiovascular Diabetology 2004, 3:3 (15 March 2004)
Abstract | Full text | PDF
| PubMed
|
|
|
30.
10994 Accesses
|
Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients
Ulrich Kintscher, Peter Bramlage, W Dieter Paar, Martin Thoenes, Thomas Unger Cardiovascular Diabetology 2007, 6:12 (3 April 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
31.
10893 Accesses
|
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease
Adam R Baker, Nancy F da Silva, David W Quinn, Alison L Harte, Domenico Pagano, Robert S Bonser, Sudhesh Kumar, Philip G McTernan Cardiovascular Diabetology 2006, 5:1 (13 January 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
32.
10817 Accesses
|
Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)
Carlos A Aguilar-Salinas, Andréia Assis-Luores-Vale, Benjamín Stockins, Hector Rengifo, José Filho, Abrahão Neto, Lísia Rabelo, Kerginaldo Torres, José Oliveira, Carlos Machado, Eliana Reyes, Victor Saavedra, Fernando Florenzano, Ma Hernández, Sergio Jiménez, Erika Ramírez, Cuauhtémoc Vazquez, Saul Salinas, Ismael Hernández, Octavio Medel, Ricardo Moreno, Paula Lugo, Ricardo Alvarado, Roopa Mehta, Victor Gutierrez, Francisco J Gómez Pérez Cardiovascular Diabetology 2004, 3:8 (23 July 2004)
Abstract | Full text | PDF
| PubMed |
|
|
|
33.
10806 Accesses
|
Low serum amylase in association with metabolic syndrome and diabetes: A community-based study
Kei Nakajima, Tohru Nemoto, Toshitaka Muneyuki, Masafumi Kakei, Hiroshi Fuchigami, Hiromi Munakata Cardiovascular Diabetology 2011, 10:34 (17 April 2011)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central |
|
|
|
34.
10605 Accesses
|
Renal protection in diabetes: lessons from ONTARGET®
Eberhard Ritz, Roland E Schmieder, Carol A Pollock Cardiovascular Diabetology 2010, 9:60 (1 October 2010)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
35.
10525 Accesses
|
The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
Robbert Meerwaldt, Thera Links, Clark Zeebregts, Rene Tio, Jan-Luuk Hillebrands, Andries Smit Cardiovascular Diabetology 2008, 7:29 (7 October 2008)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
36.
10522 Accesses
|
A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease
Enrique Z Fisman, Alexander Tenenbaum Cardiovascular Diabetology 2009, 8:38 (20 July 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central |
|
|
|
37.
10317 Accesses
|
Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)
Masaya Sakamoto, Rimei Nishimura, Taiga Irako, Daisuke Tsujino, Kiyotaka Ando, Kazunori Utsunomiya Cardiovascular Diabetology 2012, 11:92 (6 August 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
38.
10315 Accesses
|
Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus
Alexander Tenenbaum, Enrique Z Fisman, Ehud Schwammenthal, Yehuda Adler, Michal Benderly, Michael Motro, Joseph Shemesh Cardiovascular Diabetology 2003, 2:14 (23 November 2003)
Abstract | Full text | PDF
| PubMed
|
|
|
39.
10296 Accesses
|
Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors
L Romayne Kurukulasuriya, James R Sowers Cardiovascular Diabetology 2010, 9:45 (30 August 2010)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central |
|
|
|
40.
10239 Accesses
|
Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme
Odd Johansen, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Patel, Hans-Juergen Woerle Cardiovascular Diabetology 2012, 11:3 (10 January 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
41.
10162 Accesses
|
What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?
Samir G Mallat Cardiovascular Diabetology 2012, 11:32 (10 April 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
42.
10023 Accesses
|
Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
Alexander Tenenbaum, Enrique Z Fisman Cardiovascular Diabetology 2004, 3:10 (1 December 2004)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
43.
9841 Accesses
|
Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects
Radka Lichnovská, Simona Gwozdziewiczová, Jirí Hrebícek Cardiovascular Diabetology 2002, 1:4 (14 October 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
44.
9709 Accesses
|
Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism
Carmine Gazzaruso, Adriana Garzaniti, Stefano Giordanetti, Colomba Falcone, Pietro Fratino Cardiovascular Diabetology 2002, 1:5 (22 November 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
45.
9469 Accesses
|
Silent myocardial infarction in women with impaired glucose tolerance: The Northern Sweden MONICA study
Dan Lundblad, Mats Eliasson Cardiovascular Diabetology 2003, 2:9 (21 August 2003)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
46.
9194 Accesses
|
Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
Elisabeth Steinhagen-Thiessen, Peter Bramlage, Christian Lösch, Hans Hauner, Heribert Schunkert, Anja Vogt, Jürgen Wasem, Karl-Heinz Jöckel, Susanne Moebus Cardiovascular Diabetology 2008, 7:31 (15 October 2008)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
47.
9101 Accesses
|
Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records
Noboru Kitamura, Yasuo Takahashi, Shuukoh Yamadate, Satoshi Asai Cardiovascular Diabetology 2007, 6:26 (29 September 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
48.
8995 Accesses
|
A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program
Sabine Frisch, Armin Zittermann, Heiner K Berthold, Christian Götting, Joachim Kuhn, Knut Kleesiek, Peter Stehle, Heinrich Körtke Cardiovascular Diabetology 2009, 8:36 (18 July 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
49.
8990 Accesses
|
Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: Evidence for a protective role for glucosamine in atherosclerosis
Wenlan Duan, Latha Paka, Sivaram Pillarisetti Cardiovascular Diabetology 2005, 4:16 (5 October 2005)
Abstract | Full text | PDF
| PubMed
|
|
|
50.
8902 Accesses
|
Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial
Klaus Empen, Robert JA Frost, H Geiss, Carsten Otto, Klaus G Parhofer Cardiovascular Diabetology 2003, 2:17 (8 December 2003)
Abstract | Full text | PDF
| PubMed
|